BRIEF published on 07/03/2024 at 18:35, 1 year 5 months ago Evolution of governance at BOIRON Governance Nomination Strategy BOIRON
BRIEF published on 06/10/2024 at 12:25, 1 year 5 months ago Declaration of voting rights as of May 31, 2024 by the company Boiron Voting Rights Capital Actions AMF BOIRON
BRIEF published on 05/14/2024 at 15:10, 1 year 6 months ago Declaration of BOIRON voting rights as of April 30, 2024 Voting Rights Capital Actions Trade Code BOIRON
BRIEF published on 04/30/2024 at 17:35, 1 year 7 months ago BOIRON announces an Ordinary General Meeting for May 2024 Shareholders Finance General Assembly BOIRON Regulatory Documents
BRIEF published on 04/25/2024 at 16:35, 1 year 7 months ago Availability of the 2023 Annual Financial Report by BOIRON Corporate Governance Annual Financial Report Extra-financial Performance Consolidated Accounts BOIRON
BRIEF published on 04/11/2024 at 09:45, 1 year 7 months ago BOIRON announces its number of shares and voting rights as of March 31, 2024 Voting Rights Capital AMF Trade Code BOIRON
Published on 12/05/2025 at 02:35, 3 hours 53 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 28 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 23 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 28 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 57 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 37 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 2 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 13 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 17 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 28 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 43 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 44 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 27 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
